# Vitamin D Supplementation in Diabetic Nephropathy

Study · id `cardio:ct-nct01476501` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01476501](<https://clinicaltrials.gov/study/NCT01476501>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01476501

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT01476501. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT01476501, source copy `cardio:ctgov-nct01476501-2022-08-31`, retrieved 2026-10-26)
- Start date: 2011-10 (registry gives no type) (ClinicalTrials.gov record NCT01476501, source copy `cardio:ctgov-nct01476501-2022-08-31`, retrieved 2026-10-26)
- Primary completion: 2014-12 (actual) (ClinicalTrials.gov record NCT01476501, source copy `cardio:ctgov-nct01476501-2022-08-31`, retrieved 2026-10-26)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01476501, source copy `cardio:ctgov-nct01476501-2022-08-31`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01476501, source copy `cardio:ctgov-nct01476501-2022-08-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01476501-2022-08-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Vitamin D Supplementation in Diabetic Nephropathy
- Condition: Sub-optimal Vitamin D Status
- Condition: Bone Disease
- Condition: Diabetic Nephropathy
- Intervention (Drug): Vitamin D3
- Lead sponsor: University of Alberta
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: University of Alberta (`cardio:org-university-of-alberta`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Vitamin D3 supplementation, bone health and quality of life in adults with diabetes and chronic kidney disease: Results of an open label randomized clinical trial (`cardio:pubmed-27302208`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2dcb83971de9c50c112feee76f55b5b709a4212a819b68007404bfc085294f6b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
